Found 284 results
Valar Atomics has raised $1 billion in funding to propel the commercialization of its helium-cooled microreactor, aiming...
The Gulf Cooperation Council's ambitious railway project may reshape regional politics and trade, fostering greater inte...
Japan is enhancing its military capabilities with new missile systems, transitioning from a defense-only posture to a co...
The rise of AI demands a new political interplay, blending state strategy with market dynamics; an approach aptly named...
Explore how the foundational choices in education and health have shaped the economic trajectories of China and India in...
A Phase 1 trial reveals that fecal microbiome transplants may enhance tolerance in individuals with peanut allergies, sp...
Federal health officials recently convened technology leaders to discuss the future of clinical AI, aiming to shape poli...
Takeda's Orzeyful, a groundbreaking orexin receptor agonist, gains FDA approval, promising improved treatment options fo...
The FDA has approved Moderna's mRNA flu vaccine for older adults, marking a significant milestone in vaccine technology.
A new study highlights that while AI tools in healthcare show promise, their effects on outcomes remain uncertain.
With rising measles cases in 2023, experts prepare to evaluate whether the U.S. still maintains its elimination status a...
Tenax Therapeutics prepares for a pivotal Phase 3 study on a heart failure treatment, with potential implications for it...
Greg Verdine is realizing significant achievements in biotech with Parabilis and LifeMine, driving advancements in cance...
Despite the rollout of the ACCESS initiative, Medicare lacks clear guidance on available providers, leaving patients in...
Moderna's mRNA flu vaccine for older adults has received FDA approval, alongside a new narcolepsy treatment from Takeda,...
Health Secretary Robert F. Kennedy Jr. initiates decertification of Kentucky's Network for Hope amid allegations of seri...
The FDA's recent approvals of a novel drug and a vaccine highlight steady progress in biopharmaceutical development, pro...
A recent study reveals tau's role in mitochondrial dysfunction linked to neurodegeneration, opening new avenues for Alzh...
A recent Medicare policy change delays price negotiations for an AbbVie drug by seven years, raising concerns about taxp...
The FDA has approved Replimune's Tudriqev for advanced melanoma following prior rejections, underscoring urgent patient...